Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Southern Acids (M)

Market Cap 415M 100M 87.48M 81.02M 75.84M 142M 9.47B 143M 961M 372M 4.66B 377M 369M 16.18B P/E 2024
32.3x
P/E 2025 11.4x
Enterprise Value 48.03M 11.61M 10.13M 9.38M 8.78M 16.47M 1.1B 16.57M 111M 43.12M 539M 43.6M 42.66M 1.87B EV / Sales 2024
0.07x
EV / Sales 2025 0.05x
Free-Float
26.64%
Yield 2024
1.55%
Yield 2025 1.64%
Current month-1.26%
1 month-1.88%
3 months+1.29%
6 months+2.28%
Current year-1.26%
1 week 3.14
Extreme 3.14
3.14
1 month 3.1
Extreme 3.1
3.29
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 15/07/2015
Director of Finance/CFO 58 01/10/2013
Chief Tech/Sci/R&D Officer 38 16/07/2014
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 79 15/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-0.32%-8.45% 104M
-1.85%-8.64%+1.82%+329.47% 5.02B
+0.58%-2.65%+12.40%+93.35% 1.64B
0.00%-7.65%+33.06%+56.74% 728M
-0.63%-2.78%+64.19%+22.31% 698M
+2.08%+4.59%+34.03%+102.54% 533M
-1.47%-4.80%-27.41%-27.60% 507M
-0.38%-3.44%+98.20%+21.18% 479M
+0.64%-0.63%+3.57%+1.73% 366M
+0.27%-1.20%+28.55%+59.26% 299M
Average -0.08%-2.96%+24.81%+65.05% 1.04B
Weighted average by Cap. -0.80%-5.60%+15.37%+186.29%

Financials

2024 2025
Net sales 920M 223M 194M 180M 168M 315M 21B 317M 2.13B 826M 10.33B 835M 817M 35.88B 1.11B 267M 233M 216M 202M 379M 25.24B 381M 2.56B 993M 12.42B 1B 982M 43.13B
Net income 13.63M 3.3M 2.87M 2.66M 2.49M 4.67M 311M 4.7M 31.58M 12.24M 153M 12.38M 12.11M 532M 36.7M 8.87M 7.74M 7.17M 6.71M 12.58M 837M 12.66M 85.02M 32.95M 412M 33.31M 32.6M 1.43B
Net Debt -372M -90M -78.47M -72.68M -68.04M -128M -8.49B -128M -862M -334M -4.18B -338M -331M -14.51B -367M -88.71M -77.35M -71.64M -67.06M -126M -8.37B -127M -850M -329M -4.12B -333M -326M -14.31B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,683
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. 5134 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!